Clene Confident In Phase III Plans For CNM-Au8 In ALS With Six-Month Data

 
• By Alaric DeArment
  
Clene announced data on CMN-Au8 from the HEALEY ALS Platform Trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business